Palion Medical is a spin-off company from the Norwegian University of Science and Technology (NTNU) and St. Olavs Hospital, Trondheim, Norway. The company is commercializing a new medical device, “MultiGuide”.
MultiGuide enables the SPG Block treatment which targets refractory chronic migraine patients as well as cluster headache patients. The SPG Block procedure has been clinically performed more than 200 times, with promising results.
Headaches such as migraine or cluster headache are severe and disabling diseases with significant social costs as it affects young individuals during their productive years.